PR
MCID: PLY039
MIFTS: 21

Polymorphic Reticulosis (PR)

Categories: Rare diseases

Aliases & Classifications for Polymorphic Reticulosis

MalaCards integrated aliases for Polymorphic Reticulosis:

Name: Polymorphic Reticulosis 52 71
Malignant Histiocytosis 71
Nk-Cell Malignancy 52
Pr 52

Classifications:



External Ids:

UMLS 71 C0019623 C2350168

Summaries for Polymorphic Reticulosis

MalaCards based summary : Polymorphic Reticulosis, also known as malignant histiocytosis, is related to pr interval, variation in and atrial tachyarrhythmia with short pr interval. Affiliated tissues include nk cells, t cells and b cells.

Related Diseases for Polymorphic Reticulosis

Diseases related to Polymorphic Reticulosis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 407, show less)
# Related Disease Score Top Affiliating Genes
1 pr interval, variation in 12.6
2 atrial tachyarrhythmia with short pr interval 12.4
3 phosphoribosylpyrophosphate synthetase superactivity 12.3
4 pityriasis rosea 11.9
5 first-degree atrioventricular block 11.6
6 second-degree atrioventricular block 11.6
7 palindromic rheumatism 11.6
8 rheumatic fever 11.5
9 prieto x-linked mental retardation syndrome 11.4
10 pierre robin syndrome and oligodactyly 11.3
11 pierre robin syndrome 11.3
12 epidermolysis bullosa dystrophica, pretibial 11.2
13 epidermolysis bullosa pruriginosa 11.2
14 hemifacial atrophy, progressive 11.2
15 peeling skin syndrome 11.2
16 facial hemiatrophy 11.2
17 chaotic atrial tachycardia 11.2
18 breast cancer 10.6
19 atrioventricular block 10.5
20 endometrial cancer 10.5
21 progressive familial heart block, type ia 10.4
22 lethal midline granuloma 10.4
23 lymphoma 10.4
24 human immunodeficiency virus type 1 10.3
25 atrial fibrillation 10.3
26 alzheimer disease 10.3
27 pancreatic ductal adenocarcinoma 10.3
28 hepatosplenic t-cell lymphoma 10.3
29 left bundle branch hemiblock 10.3
30 pericarditis 10.3
31 lymphomatoid granulomatosis 10.3
32 adenocarcinoma 10.3
33 dengue virus 10.2
34 in situ carcinoma 10.2
35 syncope 10.2
36 peripheral t-cell lymphoma 10.2
37 cardiac conduction defect 10.2
38 hepatitis c virus 10.2
39 ductal carcinoma in situ 10.2
40 amyotrophic lateral sclerosis 1 10.2
41 progressive familial heart block, type ib 10.2
42 right bundle branch block 10.2
43 constipation 10.2
44 lateral sclerosis 10.2
45 coronary heart disease 1 10.2
46 cold agglutinin disease 10.2
47 heart block, congenital 10.1
48 pulmonary hypertension, primary, 3 10.1
49 endometriosis 10.1
50 breast ductal carcinoma 10.1
51 congestive heart failure 10.1
52 lymphoproliferative syndrome 10.1
53 frontotemporal dementia 10.1
54 back pain 10.1
55 rapidly involuting congenital hemangioma 10.1
56 combined pulmonary fibrosis-emphysema syndrome 10.1
57 pulmonary disease, chronic obstructive 10.1
58 endometrial hyperplasia 10.1
59 endometrial adenocarcinoma 10.1
60 syphilis 10.1
61 acquired immunodeficiency syndrome 10.1
62 rubella 10.1
63 hansen's disease 10.1
64 vasculitis 10.0
65 retinoblastoma 10.0
66 wolff-parkinson-white syndrome 10.0
67 anemia, autoimmune hemolytic 10.0
68 fabry disease 10.0
69 resting heart rate, variation in 10.0
70 pulmonary hypertension, primary, 2 10.0
71 adult t-cell leukemia 10.0
72 female breast cancer 10.0
73 japanese encephalitis 10.0
74 sarcoma 10.0
75 tetanus 10.0
76 leukemia 10.0
77 diarrhea 10.0
78 sick sinus syndrome 10.0
79 dental caries 10.0
80 spindle cell sarcoma 10.0
81 familial retinoblastoma 10.0
82 t-cell lymphoblastic leukemia/lymphoma 10.0
83 leukemia, t-cell, chronic 10.0
84 colorectal cancer 10.0
85 hepatocellular carcinoma 10.0
86 cardiac arrhythmia 10.0
87 hair whorl 10.0
88 glycogen storage disease ii 10.0
89 immune deficiency disease 10.0
90 leprosy 3 10.0
91 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.0
92 meningioma, radiation-induced 10.0
93 meningioma, familial 10.0
94 myocardial infarction 10.0
95 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.0
96 angina pectoris 10.0
97 deficiency anemia 10.0
98 pain agnosia 10.0
99 intrahepatic cholestasis of pregnancy 10.0
100 trachoma 10.0
101 spinal meningioma 10.0
102 heart disease 10.0
103 dilated cardiomyopathy 10.0
104 cholestasis 10.0
105 hypothyroidism 10.0
106 cholera 10.0
107 vaginitis 10.0
108 glioblastoma multiforme 10.0
109 vaccinia 10.0
110 secretory meningioma 10.0
111 lymphoplasmacyte-rich meningioma 10.0
112 inferior myocardial infarction 10.0
113 chickenpox 10.0
114 intermediate coronary syndrome 10.0
115 acute myocardial infarction 10.0
116 47,xyy 10.0
117 48,xyyy 10.0
118 pik3ca-related overgrowth syndrome 10.0
119 anaplastic large cell lymphoma 9.9
120 t-cell adult acute lymphocytic leukemia 9.9
121 t-cell prolymphocytic leukemia 9.9
122 tracheoesophageal fistula with or without esophageal atresia 9.9
123 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.9
124 exanthem 9.9
125 inflammatory bowel disease 9.9
126 cryptococcosis 9.9
127 agammaglobulinemia 9.9
128 hemolytic anemia 9.9
129 t-cell non-hodgkin lymphoma 9.9
130 atherosclerosis susceptibility 9.9
131 systemic lupus erythematosus 9.9
132 pneumothorax, primary spontaneous 9.9
133 schistosoma mansoni infection, susceptibility/ 9.9
134 atrioventricular dissociation 9.9
135 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.9
136 rheumatic fever-related antigen 9.9
137 insulin-like growth factor i 9.9
138 aging 9.9
139 late-onset retinal degeneration 9.9
140 mammographic density 9.9
141 major affective disorder 8 9.9
142 major affective disorder 9 9.9
143 bile acid malabsorption, primary 9.9
144 aortic valve disease 2 9.9
145 portal hypertension, noncirrhotic 9.9
146 tick-borne encephalitis 9.9
147 restless legs syndrome 9.9
148 brugada syndrome 9.9
149 sinoatrial node disease 9.9
150 ovarian serous carcinoma 9.9
151 endocervical adenocarcinoma 9.9
152 infective endocarditis 9.9
153 autism spectrum disorder 9.9
154 estrogen-receptor positive breast cancer 9.9
155 endocarditis 9.9
156 respiratory failure 9.9
157 mitral valve insufficiency 9.9
158 dengue disease 9.9
159 dengue hemorrhagic fever 9.9
160 dementia 9.9
161 clonorchiasis 9.9
162 schistosomiasis 9.9
163 cystic echinococcosis 9.9
164 echinococcosis 9.9
165 candidiasis 9.9
166 pneumothorax 9.9
167 heart septal defect 9.9
168 mitral valve stenosis 9.9
169 atrial heart septal defect 9.9
170 tic disorder 9.9
171 glomerulonephritis 9.9
172 lobular neoplasia 9.9
173 bipolar disorder 9.9
174 heart valve disease 9.9
175 tricuspid valve insufficiency 9.9
176 human immunodeficiency virus infectious disease 9.9
177 endometrial serous adenocarcinoma 9.9
178 hemoglobinuria 9.9
179 b-cell lymphoma 9.9
180 encephalitis 9.9
181 systolic heart failure 9.9
182 yellow fever 9.9
183 glioma 9.9
184 pityriasis rotunda 9.9
185 depression 9.9
186 chronic pain 9.9
187 fainting 9.9
188 traumatic brain injury 9.9
189 apert syndrome 9.7
190 alcohol dependence 9.7
191 arteries, anomalies of 9.7
192 atrial standstill 1 9.7
193 autoimmune disease 9.7
194 bladder cancer 9.7
195 cryoglobulinemia, familial mixed 9.7
196 multiple sclerosis 9.7
197 erythroleukemia, familial 9.7
198 esophageal cancer 9.7
199 glaucoma, primary open angle 9.7
200 hand skill, relative 9.7
201 hashimoto thyroiditis 9.7
202 attention deficit-hyperactivity disorder 9.7
203 hypertension, essential 9.7
204 multiple system atrophy 1 9.7
205 leiomyoma, uterine 9.7
206 leukemia, chronic lymphocytic 9.7
207 migraine with or without aura 1 9.7
208 obsessive-compulsive disorder 9.7
209 ovarian cancer 9.7
210 parietal foramina 1 9.7
211 parkinson disease, late-onset 9.7
212 peroxidase, salivary 9.7
213 pheochromocytoma 9.7
214 polykaryocytosis inducer 9.7
215 porphyria, acute intermittent 9.7
216 prostate cancer 9.7
217 tetralogy of fallot 9.7
218 thyroid cancer, nonmedullary, 1 9.7
219 triiodothyronine receptor auxiliary protein 9.7
220 down syndrome 9.7
221 zinc finger protein 1 9.7
222 adrenocortical carcinoma, hereditary 9.7
223 ataxia-telangiectasia 9.7
224 autism 9.7
225 osteogenic sarcoma 9.7
226 scott syndrome 9.7
227 progesterone resistance 9.7
228 arts syndrome 9.7
229 ataxia and polyneuropathy, adult-onset 9.7
230 retinitis pigmentosa 11 9.7
231 adenomyosis 9.7
232 suppression of tumorigenicity 12 9.7
233 stroke, ischemic 9.7
234 leukemia, acute myeloid 9.7
235 neural tube defects, folate-sensitive 9.7
236 yemenite deaf-blind hypopigmentation syndrome 9.7
237 macular degeneration, age-related, 1 9.7
238 ventricular fibrillation, paroxysmal familial, 1 9.7
239 cervical cancer 9.7
240 body mass index quantitative trait locus 1 9.7
241 chromosome 1p36 deletion syndrome 9.7
242 major depressive disorder 9.7
243 malaria 9.7
244 purine nucleoside phosphorylase deficiency 9.7
245 adams-oliver syndrome 2 9.7
246 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.7
247 lymphatic malformation 7 9.7
248 hyperlipoproteinemia, type iii 9.7
249 fetal akinesia deformation sequence 2 9.7
250 lipoprotein quantitative trait locus 9.7
251 kashin-beck disease 9.7
252 adrenal cortical carcinoma 9.7
253 autoimmune vasculitis 9.7
254 acute diarrhea 9.7
255 intestinal schistosomiasis 9.7
256 third-degree atrioventricular block 9.7
257 rheumatic heart disease 9.7
258 adrenal gland pheochromocytoma 9.7
259 uterine corpus endometrial carcinoma 9.7
260 generalized epilepsy with febrile seizures plus 9.7
261 paroxysmal nocturnal hemoglobinuria 9.7
262 cardiac arrest 9.7
263 fruit allergy 9.7
264 covid-19 9.7
265 endometritis 9.7
266 cysticercosis 9.7
267 trypanosomiasis 9.7
268 thalassemia 9.7
269 pre-eclampsia 9.7
270 open-angle glaucoma 9.7
271 mastitis 9.7
272 paragonimiasis 9.7
273 kuhnt-junius degeneration 9.7
274 borderline personality disorder 9.7
275 hypoparathyroidism 9.7
276 mobitz type ii atrioventricular block 9.7
277 adult respiratory distress syndrome 9.7
278 diphtheria 9.7
279 hemopericardium 9.7
280 hypertensive heart disease 9.7
281 infant gynecomastia 9.7
282 gestational diabetes 9.7
283 pericardial effusion 9.7
284 visual epilepsy 9.7
285 hypertrophic cardiomyopathy 9.7
286 allergic hypersensitivity disease 9.7
287 chagas disease 9.7
288 alveolar echinococcosis 9.7
289 bronchopneumonia 9.7
290 acute leukemia 9.7
291 gynecomastia 9.7
292 leiomyoma 9.7
293 telangiectasis 9.7
294 mucopolysaccharidosis iii 9.7
295 quadriplegia 9.7
296 guillain-barre syndrome 9.7
297 lagophthalmos 9.7
298 gout 9.7
299 porphyria 9.7
300 eclampsia 9.7
301 polyneuropathy 9.7
302 squamous cell papilloma 9.7
303 anus cancer 9.7
304 toxic shock syndrome 9.7
305 glossitis 9.7
306 disease of mental health 9.7
307 personality disorder 9.7
308 mental depression 9.7
309 lymphadenitis 9.7
310 breast fibroadenoma 9.7
311 cystitis 9.7
312 conversion disorder 9.7
313 neuritis 9.7
314 cerebral palsy 9.7
315 placental choriocarcinoma 9.7
316 hepatitis d 9.7
317 post-traumatic stress disorder 9.7
318 keratopathy 9.7
319 leptospirosis 9.7
320 acromegaly 9.7
321 thrombophilia 9.7
322 papilloma 9.7
323 myoma 9.7
324 bilirubin metabolic disorder 9.7
325 long qt syndrome 9.7
326 cryoglobulinemia 9.7
327 severe acute respiratory syndrome 9.7
328 astrocytoma 9.7
329 gliosarcoma 9.7
330 interstitial lung disease 9.7
331 papillary carcinoma 9.7
332 lipid metabolism disorder 9.7
333 lysosomal storage disease 9.7
334 demyelinating disease 9.7
335 ischemia 9.7
336 mood disorder 9.7
337 breast adenocarcinoma 9.7
338 breast disease 9.7
339 choriocarcinoma 9.7
340 adrenal cortical adenocarcinoma 9.7
341 restrictive cardiomyopathy 9.7
342 mouth disease 9.7
343 tricuspid valve stenosis 9.7
344 liver disease 9.7
345 carcinosarcoma 9.7
346 polyradiculoneuropathy 9.7
347 granulomatous endometritis 9.7
348 uremia 9.7
349 angiokeratoma 9.7
350 adenocarcinoma in situ 9.7
351 thyroid gland disease 9.7
352 ovarian cyst 9.7
353 chronic inflammatory demyelinating polyradiculoneuropathy 9.7
354 schizoaffective disorder 9.7
355 peripheral nervous system disease 9.7
356 paraplegia 9.7
357 acute stress disorder 9.7
358 mitral valve disease 9.7
359 inflammatory breast carcinoma 9.7
360 connective tissue disease 9.7
361 hepatoblastoma 9.7
362 thyroiditis 9.7
363 meningothelial meningioma 9.7
364 anthrax disease 9.7
365 chronic kidney disease 9.7
366 sporadic breast cancer 9.7
367 periampullary adenocarcinoma 9.7
368 myocarditis 9.7
369 cataract 9.7
370 influenza 9.7
371 lung disease 9.7
372 bullous pemphigoid 9.7
373 myeloid leukemia 9.7
374 neuropathy 9.7
375 lupus erythematosus 9.7
376 learning disability 9.7
377 cervix uteri carcinoma in situ 9.7
378 pemphigus 9.7
379 cleft lip 9.7
380 trichinosis 9.7
381 muscular dystrophy 9.7
382 hypoplastic left heart syndrome 9.7
383 anca-associated vasculitis 9.7
384 bidirectional tachycardia 9.7
385 cervical intraepithelial neoplasia 9.7
386 chromosomal triplication 9.7
387 ovarian epithelial cancer 9.7
388 paroxysmal cold hemoglobinuria 9.7
389 pure autonomic failure 9.7
390 uterine sarcoma 9.7
391 atrial fibrillation and stroke 9.7
392 brain injury 9.7
393 head injury 9.7
394 hypotonia 9.7
395 paresthesia 9.7
396 seizure disorder 9.7
397 spinal cord injury 9.7
398 whiplash 9.7
399 interatrial communication 9.7
400 cleft lip/palate 9.7
401 glial tumor 9.7
402 atrial standstill 9.7
403 avascular necrosis 9.7
404 benign idiopathic neonatal seizures 9.7
405 diffuse alveolar hemorrhage 9.7
406 rare tumor 9.7
407 thyroid carcinoma 9.7

Graphical network of the top 20 diseases related to Polymorphic Reticulosis:



Diseases related to Polymorphic Reticulosis

Symptoms & Phenotypes for Polymorphic Reticulosis

Drugs & Therapeutics for Polymorphic Reticulosis

Interventional clinical trials:

(showing 2, show less)
# Name Status NCT ID Phase Drugs
1 A Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib in Refractory Langerhans Cell Histiocytosis, LCH-Associated Neurodegenerative Disease, and Other Histiocytic Disorders. Not yet recruiting NCT04079179 Phase 2 Cobimetinib
2 CASPALLO: A Phase I Study Evaluating the Use of Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene After Haploidentical Stem Cell Transplantation Active, not recruiting NCT00710892 Phase 1

Search NIH Clinical Center for Polymorphic Reticulosis

Genetic Tests for Polymorphic Reticulosis

Anatomical Context for Polymorphic Reticulosis

MalaCards organs/tissues related to Polymorphic Reticulosis:

40
Nk Cells, T Cells, B Cells, Colon, Skin, Tonsil, Neutrophil

Publications for Polymorphic Reticulosis

Articles related to Polymorphic Reticulosis:

(showing 90, show less)
# Title Authors PMID Year
1
Diagnosis and management of natural killer-cell malignancies. 61
21083476 2010
2
Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features. 61
19593607 2009
3
Aggressive NK cell leukaemia after splenectomy: association with CD95-resistant memory T-cell proliferation and recalcitrant clinical course of haemophagocytic syndrome. 61
18510705 2008
4
[Future perspectives of research and clinical studies for NK-cell malignancy in Asia]. 61
18800602 2008
5
Polymorphic reticulosis: A case report. 61
23120326 2006
6
Natural killer-cell malignancies: diagnosis and treatment. 61
16179910 2005
7
Body cavity-based presentation of natural killer cell lymphoma. 61
15621817 2005
8
Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity. 61
12127554 2002
9
[Midfacial necrosis secondary to cocaine-abuse]. 61
11998527 2002
10
Blastic natural killer cell lymphoma arising from the mediastinum with terminal deoxynucleotidyl transferase expression. 61
11148466 2001
11
Low frequency of HLA-A*0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology. 61
10861473 2000
12
Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan. 61
10811105 2000
13
[Epstein-Barr virus and malignant lymphoma]. 61
10741124 2000
14
Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology. 61
10362131 1999
15
Chronological changes in incidences of polymorphic reticulosis in Korea and Japan. 61
10202275 1999
16
Acute leukemia with the phenotype of a natural killer/T cell bipotential precursor. 61
10037270 1999
17
[Polymorphic reticulosis of the rhinopharynx]. 61
10520275 1999
18
[Centrofacial lymphoma, cause of middle line granuloma syndrome. Report of a case]. 61
9927781 1998
19
Malignant lymphomas of sinonasal region, including cases of polymorphic reticulosis: a retrospective clinicopathologic analysis of 34 cases. 61
9509678 1997
20
Epstein-Barr virus in lymphoproliferative diseases in the sino-nasal region: close association with CD56+ immunophenotype and polymorphic-reticulosis morphology. 61
8985084 1997
21
Idiopathic midline granuloma--current classification and management controversies. 61
8937608 1996
22
Angiocentric T-cell lymphoma of the tonsil: a case report. 61
8935531 1996
23
The spectrum of pulmonary vasculitis. 61
8901319 1996
24
[Two cases of lethal midline granuloma thought to be of natural killer cell origin]. 61
8822254 1996
25
[On classification of changes in necrotizing lesions of the midface]. 61
9045157 1996
26
Sinonasal T-cell lymphoma in the differential diagnosis of lethal midline granuloma using in situ hybridization for Epstein-Barr virus RNA. 61
8821949 1996
27
Coxiella burnetii in polymorphic lymphocytes in tissue and blood of patients with polymorphic reticulosis. 61
8722296 1995
28
Expression of interleukin-6 in polymorphic reticulosis--immunohistochemical study of 5 cases. 61
8750057 1995
29
Polymorphic reticulosis is a neoplasm of large granular lymphocytes with CD3+ phenotype. 61
8625143 1995
30
Polymorphic reticulosis is a neoplasm of large granular lymphocytes with CD3+ phenotype. 61
7828140 1995
31
Sinonasal lymphomas. 61
7979008 1994
32
Polymorphic reticulosis: a reappraisal. 61
8026825 1994
33
EBV in situ hybridization study for non-Hodgkin's lymphomas. 61
7993589 1994
34
Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China. 61
7522272 1994
35
Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan. 61
8200002 1994
36
Lethal midline granuloma in Okinawa with special emphasis on polymorphic reticulosis. 61
8200852 1994
37
Nasal T-cell lymphoma. 61
8172815 1994
38
[An ELISA for the detection of anti-neutrophil cytoplasmic antibodies using the cytoplasmic alpha-fraction--clinical use for the diagnosis of Wegener granulomatosis and for monitoring its activity]. 61
8176533 1994
39
[Cases of lethal midline granuloma (polymorphic reticulosis) at our department in a recent 10-year period]. 61
8345394 1993
40
Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma (polymorphic reticulosis). 61
8466767 1993
41
Lethal midline granuloma: a case of Ki-1 lymphoma. 61
8191049 1993
42
Malignant lymphomas of the nasal cavity and Waldeyer's ring--clinicopathologic and immunohistochemical study. 61
1299234 1992
43
[Genotypic analysis of lethal midline granuloma]. 61
1491277 1992
44
[Polymorphic reticulosis: a type of lymphoma? Report of 3 cases]. 61
1340950 1992
45
Fireside conference 19. Wegener's granulomatosis and lethal midline granuloma. 61
1389398 1992
46
Non-Hodgkin's lymphoma confined to the nasal cavity: its relationship to the polymorphic reticulosis and results of radiation therapy. 61
2004957 1991
47
Angiocentric immunoproliferative lesion/T-cell non-Hodgkin's lymphoma and the acquired immune deficiency syndrome: a case report and review of the literature. 61
2245397 1990
48
Nasal lymphoma. A retrospective analysis of 60 cases. 61
2224776 1990
49
Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. 61
2210727 1990
50
Histopathological and immunohistochemical studies of polymorphic reticulosis. 61
2281681 1990
51
Polymorphic reticulosis with colonic lesion--a case report. 61
2278664 1990
52
Unusual presentations of lymphoma of the head and neck in childhood. 61
2319881 1990
53
Association of Epstein-Barr virus with polymorphic reticulosis. 61
2165414 1990
54
CT evaluation of polymorphic reticulosis. 61
2352632 1990
55
Treatment of granulomatous disorders of the nose and paranasal sinuses. 61
2696071 1989
56
Immunopathology of polymorphic reticulosis of the larynx. 61
2685150 1989
57
Osteocartilaginous necrosis of the sinonasal tract following cocaine abuse. 61
2770383 1989
58
Polymorphic reticulosis: T- or B-cell malignancy. 61
2788786 1989
59
Nation-wide study of lethal mid-line granuloma in Japan: frequencies of wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. 61
2744899 1989
60
Current concepts of the lethal midline granuloma syndrome. 61
2501742 1989
61
[Lymphomatoid granulomatosis vs. leprosy]. 61
2490877 1989
62
Lethal midline granuloma and lymphoproliferative disorders. 61
2769118 1989
63
Immune deficiency with polymorphic reticulosis. 61
2927928 1989
64
Polymorphic reticulosis: a malignant lymphoma of B-cell lineage. 61
2783988 1989
65
[Is Stewart's malignant midline granuloma a peripheral T-cell lymphoma? Apropos of 5 cases]. 61
2789423 1989
66
Angiocentric and angiodestructive infiltration of adult T-cell leukemia/lymphoma (ATLL) in the skin. Report of two cases. 61
3218716 1988
67
Polymorphic reticulosis limited to the upper aerodigestive tract--natural history and radiotherapeutic considerations. 61
3417488 1988
68
Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence for a monoclonal T-cell lymphoproliferative disorder. 61
3260812 1988
69
[Polymorphic reticulosis. Clinical cases]. 61
3273772 1988
70
Midline destructive granuloma: fact or fiction. 61
3626730 1987
71
Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. 61
3496014 1987
72
Midfacial necrotizing lesions. 61
3313603 1987
73
An unusual complication of polymorphic reticulosis: a case presentation. 61
3806774 1986
74
Polymorphic reticulosis with oral lesions: a case report. 61
2947614 1986
75
Dilemmas in the management of chronic nasal and sinus inflammatory diseases of unknown etiology. 61
4046701 1985
76
[Polymorphic reticulosis and full term pregnancy]. 61
3842154 1985
77
Midline "nonhealing" granuloma. 61
6595616 1984
78
Oral mucosal presentation of lymphoma: report of case. 61
6584492 1984
79
T cell lymphoma presenting clinical and morphological features resembling polymorphic reticulosis and lymphomatoid granulomatosis. 61
6608207 1983
80
[Lymphomatoid granulomatosis, polymorphic reticulosis and angioimmunoblastic lymphadenopathy with pulmonary involvement. Similar or different entities?]. 61
6838708 1983
81
Radiotherapy of polymorphic reticulosis. 61
7127005 1982
82
Midfacial necrotizing diseases. 61
7137791 1982
83
[Lymphomatoid granulomatosis with mesenteric localization. Nosologic problems (author's transl)]. 61
6287619 1982
84
Wegener's granulomatosis and polymorphic reticulosis--two diseases or one? Experience with 90 patients. 61
7469900 1981
85
Polymorphic reticulosis (lethal midline granuloma) and lymphomatoid granulomatosis: identical or distinct entities? 61
7281476 1981
86
Respiratory vasculitis. 61
7401691 1980
87
Nasal polymorphic reticulosis in a child. 61
7369202 1980
88
[Nervous system and lymphomatoid granulomatosis. Clinical, pathological and nosological considerations (author's transl)]. 61
7414147 1980
89
Polymorphic reticulosis, lymphomatoid granulomatosis. Two diseases or one? 61
713593 1978
90
The protean clinical features of polymorphic reticulosis (lethal midline granuloma). 61
933689 1976

Variations for Polymorphic Reticulosis

Expression for Polymorphic Reticulosis

Search GEO for disease gene expression data for Polymorphic Reticulosis.

Pathways for Polymorphic Reticulosis

GO Terms for Polymorphic Reticulosis

Sources for Polymorphic Reticulosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....